잠시만 기다려 주세요. 로딩중입니다.

Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis

The World Journal of Men′s Health 2020년 38권 4호 p.535 ~ 544
김재헌, 심성률, Khandwala Yash, Del Giudice Francesco, Sorensen Simon, Chung Benjamin I.,
소속 상세정보
김재헌 ( Kim Jae-Heon ) - Soonchunhyang University College of Medicine Soonchunhyang University Seoul Hospital Department of Urology
심성률 ( Shim Sung-Ryul ) - Korea University College of Medicine Department of Preventive Medicine
 ( Khandwala Yash ) - Stanford University Medical Center Department of Urology
 ( Del Giudice Francesco ) - Sapienza University of Rome Department of Urology
 ( Sorensen Simon ) - Aarhus University Hospital Department of Urology
 ( Chung Benjamin I. ) - Stanford University Medical Center Department of Urology

Abstract


Purpose: Although five-alpha reductase inhibitor (5-ARI) is one of standard treatment for benign prostatic hyperplasia (BPH) or alopecia, potential complications after 5-ARI have been issues recently. This study aimed to investigate the risk of depression after taking 5-ARI and to quantify the risk using meta-analysis.

Materials and Methods: A total of 209,940 patients including 207,798 in 5-ARI treatment groups and 110,118 in control groups from five studies were included for final analysis. Inclusion criteria for finial analysis incudes clinical outcomes regarding depression risk in BPH or alopecia patients. Overall hazard ratio (HR) and odds ratio (OR) for depression were analyzed. Moderator analysis and sensitivity analysis were performed to determine whether HR or OR could be affected by any variables, including number of patients, age, study type, and control type.

Results: The pooled overall HRs for the 5-ARI medication was 1.23 (95% confidence interval [CI], 0.99?1.54) in a random effects model. The pooled overall ORs for the 5-ARI medication was 1.19 (95% CI, 0.95?1.49) in random effects model. The sub-group analysis showed that non-cohort studies had higher values of HR and OR than cohort studies. Moderator analysis using meta-regression showed that there were no variables that affect the significant difference in HR and OR outcomes. However, in sensitivity analysis, HR was significantly increased by age (p=0.040).

Conclusions: Overall risk of depression after 5-ARI was significantly not high, however its clinical importance needs validation by further studies. These quantitative results could provide useful information for both clinicians and patients.

키워드

Alopecia; Depression; Prostatic hyperplasia; Suicide; 5-alpha reductase inhibitors

원문 및 링크아웃 정보

등재저널 정보